We believe that we are building a balanced pipeline of drug candidates that may expand the reach and benefit of existing therapeutics. Our product portfolio includes both candidates from our proprietary drug targeting platforms and in-licensed and acquired product candidates. Our current pipeline includes three clinical development programs which we are actively developing. We also have three other clinical-stage product candidates, for which we are seeking business development partners but are not actively developing, and we have four preclinical product candidates we are developing, three of which are based upon our proprietary drug-targeting platforms.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Highland Clan Creations Corp, Highland Clan Creations Corp.
SEC CIK
Corporate docs
IRS number
980379351
Latest filings (excl ownership)
CT ORDER
Confidential treatment order
5 Jan 10
10-K
2009 FY
Annual report
28 Oct 09
8-K
Raptor Pharmaceuticals and TorreyPines Therapeutics Receive
6 Oct 09
EFFECT
Notice of effectiveness
1 Oct 09
15-12G
Securities registration termination
30 Sep 09
POS AM
Prospectus update (post-effective amendment)
30 Sep 09
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Sep 09
D
$2.39M in equity / options, sold $2.39M, 4 investors
16 Sep 09
425
Business combination disclosure
31 Aug 09
Latest ownership filings
No filings